Table 1.
Subspeciality follow-up needs for babies with birth weight and or gestation risk, diagnosis, and or intervention morbidity risk indications.
| Phenotype | Neurology | Specialist nutrition | Auditory screening | Ophthalmology- ROP | Pulmonary | Pediatric orthopedic and occupational therapy | Cardiology | Surgical | General pediatrics, nutrition, growth & development |
|---|---|---|---|---|---|---|---|---|---|
| Birth weight ≤1,500 g/<32 weeks | X | X | X | ||||||
| Mechanical ventilation | X | X | X | ||||||
| Bronchopulmonary dysplasia | X | X | X | ||||||
| Convulsions/seizures | X | X | X | ||||||
| SBA/HIE | X | X | X | ||||||
| Sepsis/serious bacterial infection | X | ||||||||
| Neonatal tetanus | X | X | |||||||
| Neonatal meningitis | X | X | |||||||
| Patent Ductus Arteriosus (PDA) | X | X | |||||||
| Pulmonary hypertension | X | X | |||||||
| Kidney injury | X | ||||||||
| Hydronephrosis | X | ||||||||
| Necrotizing Enterocolitis (NEC) | X | X | |||||||
| RH/ABO isoimmunization | X | ||||||||
| HIV/VDRL exposure | |||||||||
| Hypoglycemia | X | ||||||||
| Severe jaundice | X | ||||||||
| Phototherapy treated | X | ||||||||
| Exchange transfusion | X | ||||||||
| Kernicterus | X | X | X | X | |||||
| CTEV/club foot | X | ||||||||
| Birth/tissue injury | X | ||||||||
| Paralysis | X | X | |||||||
| Down syndrome | X | ||||||||
| Facial/Lip cleft | X | X | X | X | X | ||||
| Congenital deformitiesa | X | ||||||||
| Gastroschisis | X | X | X | ||||||
| Spina Bifida | X | X | |||||||
| Hernia | X | ||||||||
| Hirschsprung disease | X | X |
ROP, retinopathy of prematurity; SBA, severe birth asphyxia; HIE, hypoxic ischaemic encephalopathy.
a
Not specified | HIV – Human Immunodeficiency Virus | VDRL - Venereal Disease Research Laboratory | CTEV – Congenital Talipes Equinovarus.